This report contains market size and forecasts of Medium and Long Chain Fat Emulsion Injection (C8-24Ve) in global, including the following market information:
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Medium and Long Chain Fat Emulsion Injection (C8-24Ve) companies in 2021 (%)
The global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medium and Long Chain Fat Emulsion Injection (C8-24Ve) include Fresenius Kabi, B. Braun, Otsuka Pharmaceutical, CR Double-Crane, Haisco, Libang, Cisen Pharmaceutical, Kelun and AnHui BBCA Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medium and Long Chain Fat Emulsion Injection (C8-24Ve) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Segment Percentages, by Type, 2021 (%)
100ml
250ml
500ml
1000ml
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Medium and Long Chain Fat Emulsion Injection (C8-24Ve) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medium and Long Chain Fat Emulsion Injection (C8-24Ve) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medium and Long Chain Fat Emulsion Injection (C8-24Ve) revenues share in global market, 2021 (%)
Key companies Medium and Long Chain Fat Emulsion Injection (C8-24Ve) sales in global market, 2017-2022 (Estimated), (K L)
Key companies Medium and Long Chain Fat Emulsion Injection (C8-24Ve) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius Kabi
B. Braun
Otsuka Pharmaceutical
CR Double-Crane
Haisco
Libang
Cisen Pharmaceutical
Kelun
AnHui BBCA Pharmaceutical
YaoPharma
Guangdong Jiabo Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
WEGO
Jiangsu Yingke Biopharmaceutical